REFERENCES
- Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol. 2001;132:7–21.
- Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab. 1991;17:124–132.
- Yaman H, Cayci T, Seyrek M, et al. Effects of vitamin A and C and melatonin on 3-nitrotyrosine formation in guinea pig heart under lipopolysaccharide-induced stress. Turk J Med Sci. 2010;40:715–721.
- Ersoz N, Guven A, Cayci T, . Comparison of the efficacy of melatonin and 1400 W on renal ischemia/reperfusion injury: A role for inhibiting iNOS. Ren Fail. 2009;31:704–710.
- Guven A, Uysal B, Akgul O, . Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail. 2008;30: 747–754.
- Kizilgun M, Poyrazoglu Y, Oztas Y, . Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 2011;33:512–517.
- Oztas E, Guven A, Turk E, . 3-Aminobenzamide, a poly ADP ribose polymerase inhibitor, attenuates renal ischemia/reperfusion injury. Ren Fail. 2009;31:393–399.
- Yanarates O, Guven A, Sizlan A, . Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail. 2008;30:931–938.
- Muller MM, Curtius HC, Herold M, . Neopterin in clinical practice. Clin Chim Acta. 1991;201:1–16.
- Ruokonen E, Ilkka L, Niskanen M, . Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand. 2002;46:398–404.
- Cayci T, Akgul EO, Kurt YG, . Cord blood and maternal serum neopterin concentrations in patients with pre-eclampsia. Clin Chem Lab Med. 2010;48:1127–1131.
- Gul H, Uysal B, Cakir E, . The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environ Toxicol Pharmacol. 2012;34:81–86.
- Yaman H, Cakir E, Ozcan O, . Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clin Biochem. 2005;38: 187–190.
- Bocci V. Ozone as Janus: This controversial gas can be either toxic or medically useful. Mediators Inflamm. 2004;13:3–11.
- Bocci VA. Scientific and medical aspects of ozone therapy: State of the art. Arch Med Res. 2006;37:425–435.
- Oter S, Korkmaz A. Relevance of hyperbaric oxygen to ozone therapy. Arch Med Res. 2006;37:917–918.
- Re L, Mawsouf MN, Menendez S, . Ozone therapy: Clinical and basic evidence of its therapeutic potential. Arch Med Res. 2008;39:17–26.
- Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses. 1996;46:150–154.
- Chatterjee PK, Patel NS, Kvale EO, . Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 2002;61:862–871.
- Altinel O, Demirbas S, Cakir E, . Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand J Clin Lab Invest. 2011;71:185–192.
- Tunc T, Uysal B, Atabek C, . Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res. 2009;155:210–216.
- Alrashed M, Abougoush M, Akgul E, . Detection method of serum and urine neopterin levels by high performance liquid chromatography and clinical applications. Gulhane MJ. 2002;44: 273–277.
- Cakir E, Akgul OE, Aydin I, . The association between neopterin and acetaminophen-induced nephrotoxicity. Ren Fail. 2010;32:740–746.
- Rabb H, Ramirez G, Saba SR, . Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol. 1996;271:F408–F413.
- Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett. 2000;486:10–13.
- Zamora ZB, Borrego A, Lopez OY, . Effects of ozone oxidative preconditioning on TNF-alpha release and antioxidant–prooxidant intracellular balance in mice during endotoxic shock. Mediators Inflamm. 2005;1:16–22.
- Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol. 2002;3:1129–1134.
- Ajamieh H, Merino N, Candelario-Jalil E, . Similar protective effect of ischemic and ozone oxidative preconditionings in liver ischemia/reperfusion injury. Pharmacol Res. 2002;45: 333–339.
- Chen H, Xing B, Liu X, . Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res. 2008; 39:169–178.
- Madej P, Plewka A, Madej JA, . Ozonotherapy in an induced septic shock I: Effect of ozonotherapy on rat organs in evaluation of free radical reactions and selected enzymatic systems. Inflammation. 2007;30:52–58.
- Bocci V, Zanardi I, Travagli V. Has oxygen-ozonetherapy a future in medicine? J Exp Integr Med. 2011;1:5–11.
- Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101:1–6.
- Bocci V, Borrelli E, Travagli V, . The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med Res Rev. 2009;29:646–682.
- Caliskan B, Guven A, Ozler M, . Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis. Scand J Clin Lab Invest. 2011;71:473–480.
- Demirbag S, Uysal B, Guven A, . Effects of medical ozone therapy on acetaminophen-induced nephrotoxicity in rats. Ren Fail. 2010;32:493–497.
- Guven A, Gundogdu G, Sadir S, . The efficacy of ozone therapy in experimental caustic esophageal burn. J Pediatr Surg. 2008;43:1679–1684.
- Guven A, Gundogdu G, Vurucu S, . Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg. 2009;44:1730–1735.
- Uysal B, Yasar M, Ersoz N, . Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas. 2010;39:9–15.